Journal of Clinical Epidemiology

Journal of Clinical Epidemiology is published by Elsevier USA and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Meta-analysis and systematic reviews, Health Systems, Economic Evaluations, Quality of Life and Statistical Methods in Clinical Trials, together about 36.7% of its articles. Its main subfields are Statistics and Probability. (generated from OpenAlex topic counts and CAS ranking data)

Metascience and innovative methods to improve population healthThe Journal of Clinical Epidemiology (JCE) aims to advance science that can improve health care decision-making and contribute to the evolving discipline of clinical epidemiology. The JCE publishes methods-focused articles across the spectrum of the research ecosystem, including primary research (qualitative, quantitative, and mixed); evidence syntheses; guidelines; and implementation science. The journal welcomes registered reports, protocols, and simulation studies that advance the journal’s aims. The JCE promotes inclusive research and health equity and is committed to ensuring a diversity of perspectives across its content, contributors, editorial board, and leadership.The journal publishes topics including:Meta-sciencePatient-oriented researchDevelopment, evaluation, and implementation of reporting guidelines Research integrity and cultureOpen scienceEmerging methodologies Developing and evaluating outcome measuresEducation and learning programs for clinical epidemiologistThe JCE does not accept the following submissions except in exceptional circumstances: Bibliometric studies and those on infodemiology, social media trends, and health informaticsPapers written primarily for a statistical audience Artificial intelligence and machine learning studies without critical evaluation of the method and transparent reportingMeta-research studies that demonstrate weaknesses or limitations in the evidence ecosystem but lack reflection on how these might be addressedEffectiveness studies, including Mendelian randomization studies and target trial emulations; systematic reviews; prevalence and incidence studies; prognostic or diagnostic research where the main focus is not on the methodsStudies limited to one country, jurisdiction, or clinical area with limited generalizability, such as: translating an outcome measure into a different language; a study focused on one clinical specialty; a Delphi/consensus-based study where all the authors are from one country; or a survey of participants from one setting or with a limited response rateStudies with a single author where it was more appropriate for a multi-disciplinary team to conduct the researchStudies that do not include patient partners as members of the research team in circumstances where that would be considered essentialAnimal studies Pharmacovigilance and pharmacoepidemiology studies

From the journal's Aims & Scope

Research area (LetPub): Public, Environmental & Occupational Health

Editor-in-chief Anneke GermeraadPublisher website

Editorial board by country: 1 in mainland China (about 1%); most named Canada 15, Australia 11, United Kingdom 10, United States 8, Netherlands 7 (81 members with a country) Editorial board ↗Publisher website · 2026-10-01

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

5.73LetPub · 2026-09-13

Impact factor (publisher)

5.8Publisher website · 2026-10-01

CiteScore 2026-06

9.4LetPub · 2026-09-13

CiteScore (publisher)

9.4Publisher website · 2026-10-01

SJR 2026-06

2.51LetPub · 2026-09-13

SNIP 2026-06

2.29LetPub · 2026-09-13

h-index

190LetPub · 2026-09-13

h-index

344OpenAlex · 2026-10-01

i10-index

5,832OpenAlex · 2026-10-01

2-year mean citedness

4.59OpenAlex · 2026-10-01

Self-citation rate

8.6%LetPub · 2026-09-13

Share of gold OA articles

52.96%LetPub · 2026-09-13

Volume

Articles per year

256LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

about 1 monthLetPub · 2026-09-13

Average acceptance (community reports)

25%LetPub · 2026-09-13

Submission to first decision

7 daysPublisher website · 2026-10-01

First decision after review

62 daysPublisher website · 2026-10-01

Submission to acceptance

128 daysPublisher website · 2026-10-01

Acceptance to publication

6 daysPublisher website · 2026-10-01

Peer review

Single anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Publisher

Elsevier USA

Country or region

ENGLAND

Language

English

Frequency

Monthly

Founded

1988

ISSN

0895-4356

Electronic ISSN

1878-5921

Official links

• Journal homepage ↗OpenAlex
• Submission system ↗Publisher website
• Special issues ↗Publisher website